Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

NCT00608374

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Newcastle Mater Misericordiae Hospital Waratah, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Queen Elizabeth Hospital Woodville, South Australia, Australia
View all 49 locations
View Trial Details
Completed

Quality of Life in Children Treated for Cancer

NCT00005881

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +27 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
View all 17 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00005977

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 119 locations
View Trial Details
Completed

Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00012051

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • Meander Medisch Centrum Amersfoort, Netherlands
  • Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
View all 17 locations
View Trial Details
Completed

Aminocamptothecin in Treating Patients With T-cell Lymphoma

NCT00002635

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

NCT00002543

Conditions
Brain and Central Nervous System Tumors, Burkitt Lymphoma, Central Nervous System Neoplasms, +33 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Floating Hospital Infants and Children Boston, Massachusetts, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

NCT00098332

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Stanford Comprehensive Cancer Center - Stanford Stanford, California, United States
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
View Trial Details

Related conditions